Author:
Wysocki P J,Kazimierczak U,Suchorska W,Kotlarski M,Malicki J,Mackiewicz A
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference54 articles.
1. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 2007; 356: 2271–2281.
2. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007; 356: 115–124.
3. Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007; 356: 125–134.
4. Wysocki PJ, Zolnierek J, Szczylik C, Mackiewicz A . Targeted therapy of renal cell cancer. Curr Opin Investig Drugs 2008; 9: 570–575.
5. Motzer RJ, Rini BI, Bukowski RM, Curti BD, George DJ, Hudes GR et al. Sunitinib in patients with metastatic renal cell carcinoma. JAMA 2006; 295: 2516–2524.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献